Related Experiment Video
Updated: Jan 17, 2026
09:19
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
26.2K
Medication Adherence: A Reimbursable Theory-Guided Evidence-Based Educational Intervention for Patients With
Amanda E George1, Melinda Hermanns2, Diane B Monsivais3
1University of Texas Health East Texas Movement Disorders Center, Tyler, TX, USA.
Research and Theory for Nursing Practice
|September 22, 2025
Summary
Improving medication adherence in Parkinson's disease patients significantly boosts quality of life. Evidence-based interventions increase adherence by 26% and improve patient well-being.
Area of Science:
- Neurology
- Health Economics
- Quality Improvement
Background:
- Parkinson's disease affects over 1.2 million US patients, costing $79 billion annually.
- Medication adherence is a major challenge in managing this progressive neurodegenerative disease.
- Complex medication regimens negatively impact patient adherence.
Purpose of the Study:
- Discuss medication adherence challenges in Parkinson's disease.
- Describe a theory-guided, evidence-based intervention to enhance medication adherence.
- Explore the economic implications of adherence interventions in outpatient settings.
Main Methods:
- Pilot chart review of 40 patients revealed 60% nonadherence.
- Implemented an evidence-based practice quality improvement project.
- Utilized Parkinson's Disease Questionnaire 39 and Morisky, Green, Levine Scale for pre/post measurements.
Main Results:
- Medication adherence increased by 26%.
- Quality of life improved by 18%.
- Intervention aligns with CMS guidelines for healthcare reimbursement and pharmaceutical economics.
Conclusions:
- Integrating medication adherence teaching improves patient outcomes and provider relationships.
- Evidence-based adherence interventions can enhance patient well-being.
- Healthcare systems can improve outcomes and revenue through adherence programs and proper coding.
Related Concept Videos
01:24Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
01:28Drug Therapy
245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
245
01:15Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
01:25Peritoneal Dialysis III: Nursing Management
676
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
676
01:27Peripheral Artery Disease III: Interprofessional Care
248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248